Questions
Tournaments
Services
News

Questions
Tournaments

Questions

Questions

36 forecasters

5

36 forecasters

Health & Pandemics

Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?

ResolvedYes

No key factors yetAdd some that might influence this forecast.

Public Benefit Corporation

Metaculus is an online forecasting platform focusing on topics of global importance.

ExploreQuestions Tournaments Tournaments for AI bots FutureEval

ServicesLaunch a Tournament Private Instances Pro Forecasters

CompanyAboutCareers FAQ

ResourcesForecasting Resources For Journalists API

Guidelines Privacy Policy Terms of Use

0 comments29 forecasters

Semaglutide/Cagrilintide Approval by 2027

1 comment53 forecasters

Oral Semaglutide Approval by 2027

5 comments49 forecasters

GLP-1-based drug approval by 2029

5 comments63 forecasters

Semaglutide Approval Withdrawal by 2027

3 comments15 forecasters

Date Weight Loss Drug >25% Body Weight

Current estimate

2 comments8 forecasters

Will the FDA reclassify retatrutide as a biologic by 2029?

15 comments52 forecasters

American Obesity Percentage in 2032

Current estimate

36 comments157 forecasters

FDA Approval for Senolytic Therapy by 2030